Pharmacokinetics and Pharmacodynamics of Tecarfarin, a Novel Vitamin K Antagonist Oral Anticoagulant

Thrombosis and Haemostasis - Germany
doi 10.1160/th16-08-0623
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Safety of Switching From Vitamin K Antagonist to Non-Vitamin K Antagonist Oral Anticoagulant in Frail Elderly With Atrial Fibrillation: Rationale and Design of the FRAIL-AF Randomised Controlled Trial

BMJ Open
Medicine
2019English

Pharmacological Profile of Non-Vitamin K Antagonist Oral Anticoagulants

African Journal of Pharmacy and Pharmacology
2017English

Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan

Clinical Pharmacokinetics
Pharmacology
2015English

Vitamin K Antagonist Embryofetopathy

2020English

Pharmacokinetics and Pharmacodynamics of a Novel Acetylcholinesterase Inhibitor, DMNG-3

Acta Neurobiologiae Experimentalis
MedicineNeuroscience
2016English

Pharmacokinetics, Pharmacodynamics and Tolerability of a Potent, Non-Peptidic, GP IIb/IIIa Receptor Antagonist Following Multiple Oral Administrations of a Prodrug Form

Thrombosis and Haemostasis
Hematology
1998English

Use of Non-Vitamin K Antagonist Oral Anticoagulants 2008-2016: A Danish Nationwide Cohort Study

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Effective Management of Venous Thromboembolism in the Community: Non-Vitamin K Antagonist Oral Anticoagulants

International Journal of General Medicine
Medicine
2016English

Pharmacokinetics and Pharmacodynamics of Suxamethonium

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy